In APP/PS1 AD mice, it was also found that TMAO is associated with and may lead to increased levels of apolipoprotein J (or clusterin, CLU), a risk factor for AD, which increases the activity of β-secretase, which is involved in amyloid accumulation, promoting cognitive impairment [58,60]. Here, APP is linked to Cognitive impairment.